Evofem Biosciences Inc (EVFM)
0.0115
0.00 (0.00%)
USD |
OTCM |
Jun 27, 13:38
Evofem Biosciences Revenue (Quarterly): 3.603M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.603M |
| December 31, 2023 | 4.839M |
| September 30, 2023 | 5.112M |
| June 30, 2023 | 2.458M |
| March 31, 2023 | 5.809M |
| December 31, 2022 | 0.181M |
| September 30, 2022 | 6.371M |
| June 30, 2022 | 6.034M |
| Date | Value |
|---|---|
| March 31, 2022 | 4.251M |
| December 31, 2021 | 3.57M |
| September 30, 2021 | 1.712M |
| June 30, 2021 | 1.857M |
| March 31, 2021 | 1.105M |
| December 31, 2020 | 0.168M |
| September 30, 2020 | 0.278M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.168M
Minimum
Dec 2020
6.371M
Maximum
Sep 2022
3.156M
Average
3.57M
Median
Dec 2021
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.809M |
| Total Expenses (Quarterly) | 6.447M |
| EPS Diluted (Quarterly) | -0.16 |
| Enterprise Value | 42.98M |
| Gross Profit Margin (Quarterly) | 81.02% |
| Profit Margin (Quarterly) | -133.5% |
| Earnings Yield | -52.59K% |
| Normalized Earnings Yield | -54333.37 |